华昊中天医药-B(02563)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02563 华昊中天医药-B

圣诞节休市 12-24 09:04:18

3.300

+0.000

0.00%

最高3.300	最低3.300	成交量0.00
今开3.300	昨收3.300	日振幅0.00%
总市值12.03亿	流通市值7.15亿	总股本3.65亿
成交额0.00	换手率0.00%	流通股本2.17亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02563","market":"HK","secType":"STK","nameCN":"华昊中天医药-B","latestPrice":3.3,"timestamp":1766538258680,"preClose":3.3,"halted":0,"volume":0,"delay":0,"floatShares":216720857,"shares":364588000,"eps":-0.45257690674671064,"marketStatus":"圣诞节休市","change":0,"latestTime":"12-24 09:04:18","open":3.3,"high":3.3,"low":3.3,"amount":0,"amplitude":0,"askPrice":3.4,"askSize":1400,"bidPrice":2.8,"bidSize":400,"shortable":0,"etf":0,"ttmEps":-0.39245707420915116,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":7,"adr":0,"listingDate":1730304000000,"exchange":"SEHK","adjPreClose":3.3,"openAndCloseTimeList":[[1766539800000,1766548800000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02563","defaultTab":"news","newsList":[{"id":"2592691845","title":"华昊中天医药-B(02563)：优替德隆治疗乳腺癌脑转移美国关键临床研究首例患者用药","url":"https://stock-news.laohu8.com/highlight/detail?id=2592691845","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592691845?lang=zh_cn&edition=full","pubTime":"2025-12-17 21:29","pubTimestamp":1765978175,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华昊中天医药-B 发布公告,本公司全资美国子公司Biostar Pharma, Inc.已完成其一项重要海外临床研究的首例患者给药：UTD1联合卡培他滨治疗HER2阴性乳腺癌脑转移美国关键注册临床研究。优替德隆也被美国FDA授予治疗乳腺癌脑转移的孤儿药资格。晚期乳腺癌患者约20–50%会发生脑部转移。优替德隆有望改变现状，为这类患者带来新的治疗手段和生存希望。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382804.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1515","BK1574","159938","02563","09939"],"gpt_icon":0},{"id":"1113420854","title":"打破“不可治愈”：华昊中天医药-B的Utd1在美国首例患者接受乳腺癌脑转移的关键临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1113420854","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113420854?lang=zh_cn&edition=full","pubTime":"2025-12-16 12:57","pubTimestamp":1765861030,"startTime":"0","endTime":"0","summary":"打破“不可治愈”：华昊中天医药-B的Utd1在美国首例患者接受乳腺癌脑转移的关键临床试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02563","BK1161"],"gpt_icon":0},{"id":"2590512559","title":"华昊中天医药-B(02563)：法院批准公司委任接管人接管子基金的申请 公司已联系接管人以推进接管程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2590512559","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590512559?lang=zh_cn&edition=full","pubTime":"2025-12-11 22:52","pubTimestamp":1765464737,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华昊中天医药-B(02563)发布公告，内容有关赎回LFM Stable Income Fund SP的认购，开曼群岛大法院(金融服务法庭)于2025年12月3日作出判决，批准公司有关委任一名接管人接管子基金的申请。法院根据认购函的条款认定US-Biostar为债权人。公司法律顾问已与获委任接管人进行沟通，接管人将根据开曼群岛法律启动LFM Fund的清盘呈请及接管程序。公司已于2025年12月10日联系接管人以推进接管程序。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380632.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1161","09939","02563","159938","BK1574"],"gpt_icon":0},{"id":"2590347313","title":"华昊中天医药-B12月09日主力净流入13.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2590347313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590347313?lang=zh_cn&edition=full","pubTime":"2025-12-09 16:15","pubTimestamp":1765268122,"startTime":"0","endTime":"0","summary":"12月09日, 华昊中天医药-B股价涨4.76%，报收3.30元，成交金额54.9万元，换手率0.08%，振幅12.38%，量比4.02。华昊中天医药-B今日主力资金净流入13.7万元，上一交易日主力净流出0万元。该股近5个交易日上涨7.84%，主力资金累计净流入13.7万元；近20日主力资金累计净流出3.0万元，其中净流出天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120916170197981c00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120916170197981c00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02563","BK1574","BK1515","09939","BK1161"],"gpt_icon":0},{"id":"2588177010","title":"华昊中天医药-B盘中异动 早盘股价大涨12.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588177010","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588177010?lang=zh_cn&edition=full","pubTime":"2025-12-01 09:46","pubTimestamp":1764553596,"startTime":"0","endTime":"0","summary":"2025年12月01日早盘09时46分，华昊中天医药-B股票出现异动，股价快速拉升12.01%。截至发稿，该股报3.450港元/股，成交量6600股，换手率0.00%，振幅1.62%。华昊中天医药-B股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，华昊中天医药-B、来凯医药-B、中基长寿科学涨幅较大，振幅较大的相关个股有银诺医药-B、中基长寿科学、康诺亚-B，振幅分别为15.93%、5.17%、4.57%。华昊中天医药-B公司简介：公司是一家专注于肿瘤治疗领域的创新药企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512010946369788b0ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512010946369788b0ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02563","09939","BK1161","BK1515","BK1574"],"gpt_icon":0},{"id":"2588719615","title":"华昊中天医药-B(02563)：法律顾问已向LFM Oversea Investment Limited发出法定要求偿债书","url":"https://stock-news.laohu8.com/highlight/detail?id=2588719615","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588719615?lang=zh_cn&edition=full","pubTime":"2025-12-01 08:14","pubTimestamp":1764548062,"startTime":"0","endTime":"0","summary":"据LFM Fund经理告知，LFM Fund曾认购Global Peace International Limited本金额为500万美元的票据，将于2026年3月到期，并已将相应资金支付予Global Peace。有关LFM Fund的接管申请已于2025年11月19日在开曼群岛进行审理，届时法院将裁定是否应由法院指定的接管人清算LFM Fund，预计判决将于两周内作出。同时，公司法律顾问于2025年11月21日向LFM Fund经理的唯一股东LFM Oversea Investment Limited发出法定要求偿债书，要求其根据认购协议的条款及承诺函，对LFM Fund的赎回承担连带保证责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375725.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02563","159938","09939","BK1161","BK1515"],"gpt_icon":0},{"id":"1171208602","title":"北京华昊中天生物医药股份有限公司2024财年年报：完善激励与治理举措","url":"https://stock-news.laohu8.com/highlight/detail?id=1171208602","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171208602?lang=zh_cn&edition=full","pubTime":"2025-11-28 20:47","pubTimestamp":1764334050,"startTime":"0","endTime":"0","summary":"年报指出，于截至2024年12月31日止年度内，公司重点推进员工激励计划，并披露了多位董事及员工参与者的授予数量和行使价等信息。该激励计划不设到期日，以绩效条件为行权前提，体现了公司对关键人才的重视，以及通过绩效目标提升经营效率的考量。公告还强调了与关联交易相关的制度与合规措施，确保交易信息透明及程序合规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02563"],"gpt_icon":0},{"id":"2584085239","title":"华昊中天医药-B11月19日主力净流出16.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2584085239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584085239?lang=zh_cn&edition=full","pubTime":"2025-11-19 16:15","pubTimestamp":1763540140,"startTime":"0","endTime":"0","summary":"11月19日，华昊中天医药-B股价收平报3.08元，成交金额33.3万元，换手率0.05%，振幅2.60%，量比2.49。华昊中天医药-B今日主力资金净流出16.7万元，上一交易日主力净流出0万元。该股近5个交易日下跌3.75%，主力资金累计净流出16.7万元；近20日主力资金累计净流出370.2万元，其中净流出天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511191619019772f4ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511191619019772f4ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","BK1161","02563","09939"],"gpt_icon":0},{"id":"2584845679","title":"华昊中天医药-B盘中异动 急速跳水5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584845679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584845679?lang=zh_cn&edition=full","pubTime":"2025-11-18 13:36","pubTimestamp":1763444162,"startTime":"0","endTime":"0","summary":"2025年11月18日下午盘13时36分，华昊中天医药-B股票出现波动，股价快速下挫5.45%。华昊中天医药-B股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，中生北控生物科技、拨康视云-B、药捷安康-B涨幅较大，振幅较大的相关个股有中生北控生物科技、思路迪医药股份、帝王国际投资，振幅分别为29.41%、18.44%、11.11%。华昊中天医药-B公司简介：公司是一家专注于肿瘤治疗领域的创新药企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118133602950b76e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118133602950b76e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","02563","09939","BK1574","BK1161"],"gpt_icon":0},{"id":"2579846324","title":"港股异动 | 华昊中天医药-B(02563)一度跌超37% 上市届满一年迎来大额解禁","url":"https://stock-news.laohu8.com/highlight/detail?id=2579846324","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579846324?lang=zh_cn&edition=full","pubTime":"2025-10-31 10:52","pubTimestamp":1761879145,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华昊中天医药-B(02563)一度跌超37%，截至发稿，跌29.98%，报3.55港元，成交额581.98万港元。消息面上，华昊中天医药上市届满一年，今日迎来大额解禁，累计解禁股数约2.46亿股。今年上半年，华昊中天医药实现营业收入1478.7万元(人民币，下同)，同比减少55.36%；净亏损5404.1万元，同比收窄23.41%；基本每股亏损0.15元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363502.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1161","09939","BK1515","BK1574","02563"],"gpt_icon":0},{"id":"2575400221","title":"华昊中天医药-B(02563)股东将股票存入华泰香港 存仓市值1.25亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575400221","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575400221?lang=zh_cn&edition=full","pubTime":"2025-10-15 08:26","pubTimestamp":1760487971,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，10月14日，华昊中天医药-B(02563)股东将股票存入华泰香港，存仓市值1.25亿港元，占比7.91%。华昊中天医药-B发布截至2025年6月30日止六个月中期业绩，营业收入1478.7万元(人民币，下同)，同比减少55.36%；净亏损5404.1万元，同比收窄23.41%；基本每股亏损0.15元。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1355107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","09939","02563","BK1574","BK1515","159938"],"gpt_icon":0},{"id":"1117476575","title":"华昊中天医药-B连续完成优替德隆胶囊(UTD2)两项II/III期多区域临床试验首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1117476575","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117476575?lang=zh_cn&edition=full","pubTime":"2025-09-15 20:05","pubTimestamp":1757937919,"startTime":"0","endTime":"0","summary":"华昊中天医药-B连续完成优替德隆胶囊(UTD2)两项II/III期多区域临床试验首例患者给药","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02563","BK1161"],"gpt_icon":0},{"id":"2566986021","title":"华昊中天医药-B09月10日主力净流入41.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2566986021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566986021?lang=zh_cn&edition=full","pubTime":"2025-09-10 16:15","pubTimestamp":1757492138,"startTime":"0","endTime":"0","summary":"09月10日, 华昊中天医药-B股价涨4.92%，报收8.96元，成交金额200.4万元，换手率0.11%，振幅8.78%，量比2.74。华昊中天医药-B今日主力资金净流入41.3万元，上一交易日主力净流出0万元。该股近5个交易日上涨3.70%，主力资金累计净流入41.3万元；近20日主力资金累计净流入488.9万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091016183597850fbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091016183597850fbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","09939","02563","BK1574"],"gpt_icon":0},{"id":"1125496327","title":"异动解读 | 华昊中天医药-B盘中大跌6.33%，中期业绩收入大幅下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=1125496327","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125496327?lang=zh_cn&edition=full","pubTime":"2025-08-29 09:42","pubTimestamp":1756431763,"startTime":"0","endTime":"0","summary":"华昊中天医药-B今日盘中大跌6.33%，引发市场关注。该公司昨日晚间发布的2025年中期业绩报告显示，尽管亏损有所收窄，但收入大幅下滑，可能是导致股价下跌的主要原因。根据公告，华昊中天医药截至2025年6月30日的六个月内，公司股东应占亏损为5404.1万元人民币，较去年同期的7056万元人民币有所收窄。分析人士指出，虽然华昊中天医药的亏损幅度有所收窄，但收入的显著下滑可能引发了投资者对公司未来增长前景的担忧。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02563"],"gpt_icon":0},{"id":"2562036612","title":"华昊中天医药-B(02563)发布中期业绩 净亏损5404.1万元 同比收窄23.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562036612","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562036612?lang=zh_cn&edition=full","pubTime":"2025-08-28 19:15","pubTimestamp":1756379723,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华昊中天医药-B(02563)发布截至2025年6月30日止六个月中期业绩，营业收入1478.7万元(人民币，下同)，同比减少55.36%;净亏损5404.1万元，同比收窄23.41%;基本每股亏损0.15元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1337513.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1574","09939","02563","BK1515","BK1161"],"gpt_icon":0},{"id":"2556854473","title":"华昊中天医药-B08月04日主力净流入35.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2556854473","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556854473?lang=zh_cn&edition=full","pubTime":"2025-08-04 16:15","pubTimestamp":1754295325,"startTime":"0","endTime":"0","summary":"08月04日, 华昊中天医药-B股价涨0.26%，报收7.78元，成交金额93.4万元，换手率0.06%，振幅3.22%，量比1.37。华昊中天医药-B今日主力资金净流入35.3万元，上一交易日主力净流出0万元。该股近5个交易日下跌2.26%，主力资金累计净流入54.0万元；近20日主力资金累计净流出35.7万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804164728a6d1fedf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804164728a6d1fedf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","02563","BK1574","BK1161","BK1515"],"gpt_icon":0},{"id":"2555704967","title":"华昊中天医药-B07月30日主力净流入18.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2555704967","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555704967?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:15","pubTimestamp":1753863325,"startTime":"0","endTime":"0","summary":"07月30日, 华昊中天医药-B股价涨0.39%，报收7.79元，成交金额131.9万元，换手率0.08%，振幅3.61%，量比2.38。华昊中天医药-B今日主力资金净流入18.7万元，上一交易日主力净流出0万元。该股主力净额占比0.01%，港股市场排名311/2674。|07月30日主力加仓幅度排名||#|股票简称|主力净额占比|#|PACIFICLEGEND|3.71%|#|嘉鼎国际集团|3.11%|#|山东墨龙|2.80%|#|...|...|#311|华昊中天医药-B|0.01%|（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730165320a46b3eee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730165320a46b3eee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02563","BK1574","BK1515","09939","BK1161"],"gpt_icon":0},{"id":"2554773586","title":"华昊中天医药-B07月28日主力净流出21.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2554773586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554773586?lang=zh_cn&edition=full","pubTime":"2025-07-28 16:15","pubTimestamp":1753690533,"startTime":"0","endTime":"0","summary":"07月28日, 华昊中天医药-B股价跌0.62%，报收7.96元，成交金额142.0万元，换手率0.08%，振幅5.99%，量比3.12。华昊中天医药-B今日主力资金净流出21.4万元，上一交易日主力净流出0万元。该股近5个交易日下跌2.92%，主力资金累计净流出21.4万元；近20日主力资金累计净流出310.6万元，其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728165221a4675fb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728165221a4675fb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02563","BK1515","BK1574","09939","BK1161"],"gpt_icon":0},{"id":"2553278969","title":"华昊中天医药-B(02563.HK)委任大信会计师事务所(特殊普通合伙)为核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2553278969","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553278969?lang=zh_cn&edition=full","pubTime":"2025-07-24 22:46","pubTimestamp":1753368404,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159938","BK1161","02563","BK1515","BK1574","09939"],"gpt_icon":0},{"id":"2553789522","title":"华昊中天医药-B委任大信为公司新核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2553789522","media":"格隆汇","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553789522?lang=zh_cn&edition=full","pubTime":"2025-07-24 22:39","pubTimestamp":1753367971,"startTime":"0","endTime":"0","summary":"格隆汇7月24日丨华昊中天医药-B(02563.HK)公告，大信国际(香港)会计师事务所退任公司核数师。董事会已议决于大信退任后建议委任大信会计师事务所(特殊普通合伙)为公司核数师。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072422394194b8858b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072422394194b8858b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","09939","02563","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biostar-pharm.com","stockEarnings":[{"period":"1week","weight":0.0312},{"period":"1month","weight":0.0645},{"period":"3month","weight":-0.6038},{"period":"6month","weight":-0.2517},{"period":"1year","weight":-0.8992},{"period":"ytd","weight":-0.8325}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0251},{"period":"6month","weight":0.0632},{"period":"1year","weight":0.2846},{"period":"ytd","weight":0.2871}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京华昊中天生物医药股份有限公司是一家主要从事创新药研发、生产及销售的中国公司。该公司的产品及管线主要包括优替德隆注射液、优替德隆胶囊、优替德隆纳米剂型、优替德隆抗体偶联药物（ADC）、BG22、BG18和BG44。该公司的产品主要用于治疗复发或转移性乳腺癌、人类表皮生长因子受体2（HER2）阴性乳腺癌新辅助治疗、晚期非小细胞肺癌（NSCLC）、实体瘤、乳腺癌脑转移、肺癌脑转移等脑部肿瘤适应症。该公司主要在国内市场开展业务。","exchange":"SEHK","name":"华昊中天医药-B","nameEN":"BIOSTAR PHARM-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华昊中天医药-B(02563)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华昊中天医药-B(02563)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华昊中天医药-B,02563,华昊中天医药-B股票,华昊中天医药-B股票老虎,华昊中天医药-B股票老虎国际,华昊中天医药-B行情,华昊中天医药-B股票行情,华昊中天医药-B股价,华昊中天医药-B股市,华昊中天医药-B股票价格,华昊中天医药-B股票交易,华昊中天医药-B股票购买,华昊中天医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华昊中天医药-B(02563)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华昊中天医药-B(02563)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}